Summary &horbar; The effect of 17!-estradiol on calcitonin (CT) and calcitonin-gene-related peptide (CGRP) secretions in the murine CA-77 C cell line was studied after 1, 3, 5 and 6 d of treatment. The release of both CT and CGRP significantly increased 1, 3, 5 and 6 d after addition of 0.1 Ilmol/l estradiol alone to the culture medium. The C cell content of both peptides also increased after 6 d of treatment with the same dose of estrogen. The enhanced CT and CGRP secretions induced by 17(3-estradiol were not inhibited by the simultaneous addition of 5 wmol/I of all-trans-retinoic acid. Dexamethasone alone increased the release of both peptides within 6 d. However, when cells were treated simultaneously with estradiol and 1 pmol/I dexamethasone, the addition of retinoic acid blunted both the CT and CGRP secretions induced by dexamethasone. These results showed that the positive effects of 17(3-estradiol on both CT and CGRP secretions were modulated by dexamethasone and retinoic acid.
INTRODUCTION
Estrogen therapy has been used to inhibit bone resorption and therefore to prevent or to treat osteoporosis in postmenopausal women (Genant et al, 1983) . It remains controversial whether this estrogen effect occurs directly at the bone level only or whether it is at least partially mediated via the stimulation of calcitonin (CT) secretion.
It was recently suggested that osteocytes are major skeletal estrogen target cells in 3 different species (Braidman et al, 1995) . One possible mediating hormone is CT, which, by reducing bone resorption, could prevent or reduce osteoporosis. Several investigators have shown that the circulating concentrations of CT are decreased in the oophorectomized or postmenopausal state (Milhaud et al, 1978) , and that estrogen increases CT secretion (Morimoto et al, 1980) . In oophorectomized rats, the plasma CT response to a calcium challenge is impaired and can be restored to normal levels by estrogen replacement therapy (Catherwood et al, 1983) . Rat pup thyroid incubation studies demonstrate that estradiol can stimulate CT secretion in vitro (Greenberg et al, 1986) . In contrast, in the human C cell carcinoma cell line (TT) with well-documented estrogen receptors, estradiol induces a dose-dependent inhibition of CT secretion (Lazaretti-Castro et al, 1991) . ). Since estrogen receptors were recently detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in rat C cells (Naveh-Many et al, 1992) , we investigated the effects of 17R-estradiol on CT and calcitonin-gene-related peptide (CGRP) secretion in the murine C cell line (CA-77).
The interaction of glucocorticoids and retinoic acid on the effects of estrogen was also analysed.
MATERIALS AND METHODS

Cell culture methodology
The Ca-77 cells were maintained in Dulbecco modified Eagle's medium (DMEM)/Ham's F10 0 (1:1) (Gibco/BRL, France) supplemented with 10 0 !g/ml insulin (Sigma), 3 x 10-a M sodium selenite (Gibco/BRL, France), 5 pg/mi transferrin (Gibco/BRL, France), 110 mg/I sodium pyruvate (Gibco/BRL, France), and a mixture of antibiotics (100 units/ml penicillin + 100 pg/ml streptomycin; Gibco/BRL, France). Cells were plated at an initial density of 4 x 10 4 cells/cm 2 in a medium containing DMEM/Ham's F10 (1:1), 10% heat-inactivated fetal calf serum (J Boy, Reims, France), 110 mg/I sodium pyruvate, 100 units/ml penicillin, and 100 pg/ml streptomycin. After 48 h of plating, the medium was changed and replaced by the growth medium described above; the growth medium with fresh hormone was changed each day. Cells were continuously exposed to the hormones. Dexamethasone (Sigma), all-trans-retinoic acid (Sigma), and 17p-estradiol (Sigma) were dissolved in absolute ethanol and then in phosphate-buffered saline (PBS) to reach a final ethanol concentration of 0,005% in the growth medium. Controls with the same volume of vehicle were used in each case.
Other methods
Cell culture medium was collected and treated as previously described (Wind et al, 1993) (Lamari et al, 1994) , an increase in (table I) in comparison to the dexamethasone group. On day 6 of treatment, 5 x 10-6 mol/I alltrans-retinoic acid clearly decreased the release of both CT and CGRP (figs 1 and 2). As compared to the effects in cells cotreated with estradiol and dexamethasone, a decrease in the secretion of both CT and CGRP occurred when the cells were exposed to the simultaneous action of estradiol, dexamethasone, and all-transretinoic acid (figs 3 and 4). This was clearly observed from days 1 to 6 of treatment, but the addition of all-trans-retinoic acid did not change the elevated C cell contents of both peptides induced by estradiol plus dexamethasone (table I) .
DISCUSSION
The C cell carcinoma cell lines offer good model systems for studying the direct effects of estrogens on CT secretion because they express estrogen receptors (Yang et al, 1988) . The dose of 17(3-estradiol used in the present in vitro studies (100 nmol/I) was shown to achieve a maximal increase of CT secretion by thyroparathyroid gland complexes of 8-d-old rat pups (Greenberg et al, 1986) (Naveh-Many et al, 1992) , and also with the fact that estradiol given to ovariectomized animals prevents the decrease in CT mRNA levels (Naveh-Many et al, 1992; Lamari et al, 1994 (Russo et al, 1988; Collignon et al, 1992) and enhances the biosynthesis and release of both CT and CGRP (Lamari et al, 1994) in CA-77 C cells has already been reported. All-trans-retinoic acid also was shown to decrease both CT and CGRP mRNAs in CA-77 C cells and the secretion of both peptides (Lamari et al, 1994 ). The present results suggest a possible interplay between dexamethasone, estrogen and retinoic acid on CT and CGRP secretion by the CA-77 C cell line.
